APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alcoholic Hepatiti Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alcoholic Hepatiti Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025186 pages

Choose your research edition.

Industry ResearchAlcoholic Hepatiti Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Alcoholic Hepatiti Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Alcoholic Hepatiti Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alcoholic Hepatiti Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alcoholic Hepatiti Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alcoholic Hepatiti Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alcoholic Hepatiti Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alcoholic Hepatiti Drug include Vital Therapies Inc, Verlyx Pharma Inc, Promethera Biosciences SA, Intercept Pharmaceuticals Inc, Immuron Ltd, GRI Bio Inc, Gilead Sciences Inc, Generon (Shanghai) Corp Ltd and Alfact Innovation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alcoholic Hepatiti Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alcoholic Hepatiti Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alcoholic Hepatiti Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alcoholic Hepatiti Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Alcoholic Hepatiti Drug Segment by Company

Vital Therapies Inc

Verlyx Pharma Inc

Promethera Biosciences SA

Intercept Pharmaceuticals Inc

Immuron Ltd

GRI Bio Inc

Gilead Sciences Inc

Generon (Shanghai) Corp Ltd

Alfact Innovation

Alcoholic Hepatiti Drug Segment by Type

IMM-124E

HepaStem

GRI-0621

F-652

Others

Alcoholic Hepatiti Drug Segment by Application

Clinic

Hospital

Others

Alcoholic Hepatiti Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alcoholic Hepatiti Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alcoholic Hepatiti Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alcoholic Hepatiti Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alcoholic Hepatiti Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alcoholic Hepatiti Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alcoholic Hepatiti Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alcoholic Hepatiti Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alcoholic Hepatiti Drug Industry Trends Table 2. Alcoholic Hepatiti Drug Industry Drivers Table 3. Alcoholic Hepatiti Drug Industry Opportunities and Challenges Table 4. Alcoholic Hepatiti Drug Industry Restraints Table 5. Global Alcoholic Hepatiti Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alcoholic Hepatiti Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alcoholic Hepatiti Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Alcoholic Hepatiti Drug Sales Market Share by Manufacturers Table 9. Global Alcoholic Hepatiti Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Alcoholic Hepatiti Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alcoholic Hepatiti Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alcoholic Hepatiti Drug Manufacturers, Product Type & Application Table 13. Global Alcoholic Hepatiti Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alcoholic Hepatiti Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of IMM-124E Table 17. Major Manufacturers of HepaStem Table 18. Major Manufacturers of GRI-0621 Table 19. Major Manufacturers of F-652 Table 20. Major Manufacturers of Others Table 21. Global Alcoholic Hepatiti Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Alcoholic Hepatiti Drug Sales by Type (2021-2026) & (k units) Table 23. Global Alcoholic Hepatiti Drug Sales by Type (2027-2032) & (k units) Table 24. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2021-2026) Table 25. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2027-2032) Table 26. Global Alcoholic Hepatiti Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Alcoholic Hepatiti Drug Revenue by Type (2021-2026) & (k units) Table 28. Global Alcoholic Hepatiti Drug Revenue by Type (2027-2032) & (k units) Table 29. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2021-2026) Table 30. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Others Table 34. Global Alcoholic Hepatiti Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Alcoholic Hepatiti Drug Sales by Application (2021-2026) & (k units) Table 36. Global Alcoholic Hepatiti Drug Sales by Application (2027-2032) & (k units) Table 37. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2021-2026) Table 38. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2027-2032) Table 39. Global Alcoholic Hepatiti Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Alcoholic Hepatiti Drug Revenue by Application (2021-2026) & (k units) Table 41. Global Alcoholic Hepatiti Drug Revenue by Application (2027-2032) & (k units) Table 42. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2021-2026) Table 43. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2027-2032) Table 44. Global Alcoholic Hepatiti Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Alcoholic Hepatiti Drug Sales by Region (2021-2026) & (k units) Table 46. Global Alcoholic Hepatiti Drug Sales Market Share by Region (2021-2026) Table 47. Global Alcoholic Hepatiti Drug Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Alcoholic Hepatiti Drug Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 51. North America Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 52. Europe Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 54. Europe Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2027-2032) & (k units) Table 61. Global Alcoholic Hepatiti Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Alcoholic Hepatiti Drug Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Alcoholic Hepatiti Drug Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2021-2026) Table 65. Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2027-2032) Table 66. Vital Therapies Inc Company Information Table 67. Vital Therapies Inc Business Overview Table 68. Vital Therapies Inc Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Vital Therapies Inc Alcoholic Hepatiti Drug Product Portfolio Table 70. Vital Therapies Inc Recent Development Table 71. Verlyx Pharma Inc Company Information Table 72. Verlyx Pharma Inc Business Overview Table 73. Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Portfolio Table 75. Verlyx Pharma Inc Recent Development Table 76. Promethera Biosciences SA Company Information Table 77. Promethera Biosciences SA Business Overview Table 78. Promethera Biosciences SA Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Promethera Biosciences SA Alcoholic Hepatiti Drug Product Portfolio Table 80. Promethera Biosciences SA Recent Development Table 81. Intercept Pharmaceuticals Inc Company Information Table 82. Intercept Pharmaceuticals Inc Business Overview Table 83. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Portfolio Table 85. Intercept Pharmaceuticals Inc Recent Development Table 86. Immuron Ltd Company Information Table 87. Immuron Ltd Business Overview Table 88. Immuron Ltd Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Immuron Ltd Alcoholic Hepatiti Drug Product Portfolio Table 90. Immuron Ltd Recent Development Table 91. GRI Bio Inc Company Information Table 92. GRI Bio Inc Business Overview Table 93. GRI Bio Inc Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. GRI Bio Inc Alcoholic Hepatiti Drug Product Portfolio Table 95. GRI Bio Inc Recent Development Table 96. Gilead Sciences Inc Company Information Table 97. Gilead Sciences Inc Business Overview Table 98. Gilead Sciences Inc Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Gilead Sciences Inc Alcoholic Hepatiti Drug Product Portfolio Table 100. Gilead Sciences Inc Recent Development Table 101. Generon (Shanghai) Corp Ltd Company Information Table 102. Generon (Shanghai) Corp Ltd Business Overview Table 103. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Portfolio Table 105. Generon (Shanghai) Corp Ltd Recent Development Table 106. Alfact Innovation Company Information Table 107. Alfact Innovation Business Overview Table 108. Alfact Innovation Alcoholic Hepatiti Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Alfact Innovation Alcoholic Hepatiti Drug Product Portfolio Table 110. Alfact Innovation Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Alcoholic Hepatiti Drug Distributors List Table 114. Alcoholic Hepatiti Drug Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Alcoholic Hepatiti Drug Product Image Figure 2. Global Alcoholic Hepatiti Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alcoholic Hepatiti Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Alcoholic Hepatiti Drug Sales (2021-2032) & (k units) Figure 5. Global Alcoholic Hepatiti Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alcoholic Hepatiti Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. IMM-124E Image Figure 9. HepaStem Image Figure 10. GRI-0621 Image Figure 11. F-652 Image Figure 12. Others Image Figure 13. Global Alcoholic Hepatiti Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Alcoholic Hepatiti Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alcoholic Hepatiti Drug Sales Market Share by Type (2021-2032) Figure 16. Global Alcoholic Hepatiti Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Alcoholic Hepatiti Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Others Image Figure 22. Global Alcoholic Hepatiti Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Alcoholic Hepatiti Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Alcoholic Hepatiti Drug Sales Market Share by Application (2021-2032) Figure 25. Global Alcoholic Hepatiti Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Alcoholic Hepatiti Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2021-2032) Figure 28. North America Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 30. U.S. Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 35. Germany Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 42. China Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Alcoholic Hepatiti Drug Sales Market Share by Country (2021-2032) Figure 50. Brazil Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Alcoholic Hepatiti Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Alcoholic Hepatiti Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Alcoholic Hepatiti Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Alcoholic Hepatiti Drug Revenue (2021-2032) & (US$ Million) Figure 61. North America Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Alcoholic Hepatiti Drug Revenue (2021-2032) & (US$ Million) Figure 63. Europe Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Alcoholic Hepatiti Drug Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Alcoholic Hepatiti Drug Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Alcoholic Hepatiti Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Alcoholic Hepatiti Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • IMM-124E
  • HepaStem
  • GRI-0621
  • F-652
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Vital Therapies Inc
  • Verlyx Pharma Inc
  • Promethera Biosciences SA
  • Intercept Pharmaceuticals Inc
  • Immuron Ltd
  • GRI Bio Inc
  • Gilead Sciences Inc
  • Generon (Shanghai) Corp Ltd
  • Alfact Innovation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alcoholic Hepatiti Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alcoholic Hepatiti Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alcoholic Hepatiti Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alcoholic Hepatiti Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alcoholic Hepatiti Drug Market Dynamics
  1. 2.1 Alcoholic Hepatiti Drug Industry Trends
  2. 2.2 Alcoholic Hepatiti Drug Industry Drivers
  3. 2.3 Alcoholic Hepatiti Drug Industry Opportunities and Challenges
  4. 2.4 Alcoholic Hepatiti Drug Industry Restraints
3 Alcoholic Hepatiti Drug Market by Manufacturers
  1. 3.1 Global Alcoholic Hepatiti Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alcoholic Hepatiti Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alcoholic Hepatiti Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alcoholic Hepatiti Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alcoholic Hepatiti Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alcoholic Hepatiti Drug Manufacturers, Product Type & Application
  7. 3.7 Global Alcoholic Hepatiti Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alcoholic Hepatiti Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alcoholic Hepatiti Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alcoholic Hepatiti Drug Tier 1, Tier 2, and Tier 3
4 Alcoholic Hepatiti Drug Market by Type
  1. 4.1 Alcoholic Hepatiti Drug Type Introduction
  2. 4.1.1 IMM-124E
  3. 4.1.2 HepaStem
  4. 4.1.3 GRI-0621
  5. 4.1.4 F-652
  6. 4.1.5 Others
  7. 4.2 Global Alcoholic Hepatiti Drug Sales by Type
  8. 4.2.1 Global Alcoholic Hepatiti Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Alcoholic Hepatiti Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Alcoholic Hepatiti Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Alcoholic Hepatiti Drug Revenue by Type
  12. 4.3.1 Global Alcoholic Hepatiti Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Alcoholic Hepatiti Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Alcoholic Hepatiti Drug Revenue Market Share by Type (2021-2032)
5 Alcoholic Hepatiti Drug Market by Application
  1. 5.1 Alcoholic Hepatiti Drug Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Alcoholic Hepatiti Drug Sales by Application
  6. 5.2.1 Global Alcoholic Hepatiti Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alcoholic Hepatiti Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Alcoholic Hepatiti Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Alcoholic Hepatiti Drug Revenue by Application
  10. 5.3.1 Global Alcoholic Hepatiti Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Alcoholic Hepatiti Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Alcoholic Hepatiti Drug Revenue Market Share by Application (2021-2032)
6 Global Alcoholic Hepatiti Drug Sales by Region
  1. 6.1 Global Alcoholic Hepatiti Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alcoholic Hepatiti Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Alcoholic Hepatiti Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Alcoholic Hepatiti Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alcoholic Hepatiti Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alcoholic Hepatiti Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alcoholic Hepatiti Drug Revenue by Region
  1. 7.1 Global Alcoholic Hepatiti Drug Revenue by Region
  2. 7.1.1 Global Alcoholic Hepatiti Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alcoholic Hepatiti Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Alcoholic Hepatiti Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Alcoholic Hepatiti Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alcoholic Hepatiti Drug Revenue (2021-2032)
  8. 7.2.2 North America Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alcoholic Hepatiti Drug Revenue (2021-2032)
  11. 7.3.2 Europe Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alcoholic Hepatiti Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alcoholic Hepatiti Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alcoholic Hepatiti Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Vital Therapies Inc
  2. 8.1.1 Vital Therapies Inc Company Information
  3. 8.1.2 Vital Therapies Inc Business Overview
  4. 8.1.3 Vital Therapies Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Vital Therapies Inc Alcoholic Hepatiti Drug Product Portfolio
  6. 8.1.5 Vital Therapies Inc Recent Developments
  7. 8.2 Verlyx Pharma Inc
  8. 8.2.1 Verlyx Pharma Inc Company Information
  9. 8.2.2 Verlyx Pharma Inc Business Overview
  10. 8.2.3 Verlyx Pharma Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Verlyx Pharma Inc Alcoholic Hepatiti Drug Product Portfolio
  12. 8.2.5 Verlyx Pharma Inc Recent Developments
  13. 8.3 Promethera Biosciences SA
  14. 8.3.1 Promethera Biosciences SA Company Information
  15. 8.3.2 Promethera Biosciences SA Business Overview
  16. 8.3.3 Promethera Biosciences SA Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Promethera Biosciences SA Alcoholic Hepatiti Drug Product Portfolio
  18. 8.3.5 Promethera Biosciences SA Recent Developments
  19. 8.4 Intercept Pharmaceuticals Inc
  20. 8.4.1 Intercept Pharmaceuticals Inc Company Information
  21. 8.4.2 Intercept Pharmaceuticals Inc Business Overview
  22. 8.4.3 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Intercept Pharmaceuticals Inc Alcoholic Hepatiti Drug Product Portfolio
  24. 8.4.5 Intercept Pharmaceuticals Inc Recent Developments
  25. 8.5 Immuron Ltd
  26. 8.5.1 Immuron Ltd Company Information
  27. 8.5.2 Immuron Ltd Business Overview
  28. 8.5.3 Immuron Ltd Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Immuron Ltd Alcoholic Hepatiti Drug Product Portfolio
  30. 8.5.5 Immuron Ltd Recent Developments
  31. 8.6 GRI Bio Inc
  32. 8.6.1 GRI Bio Inc Company Information
  33. 8.6.2 GRI Bio Inc Business Overview
  34. 8.6.3 GRI Bio Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GRI Bio Inc Alcoholic Hepatiti Drug Product Portfolio
  36. 8.6.5 GRI Bio Inc Recent Developments
  37. 8.7 Gilead Sciences Inc
  38. 8.7.1 Gilead Sciences Inc Company Information
  39. 8.7.2 Gilead Sciences Inc Business Overview
  40. 8.7.3 Gilead Sciences Inc Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gilead Sciences Inc Alcoholic Hepatiti Drug Product Portfolio
  42. 8.7.5 Gilead Sciences Inc Recent Developments
  43. 8.8 Generon (Shanghai) Corp Ltd
  44. 8.8.1 Generon (Shanghai) Corp Ltd Company Information
  45. 8.8.2 Generon (Shanghai) Corp Ltd Business Overview
  46. 8.8.3 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Generon (Shanghai) Corp Ltd Alcoholic Hepatiti Drug Product Portfolio
  48. 8.8.5 Generon (Shanghai) Corp Ltd Recent Developments
  49. 8.9 Alfact Innovation
  50. 8.9.1 Alfact Innovation Company Information
  51. 8.9.2 Alfact Innovation Business Overview
  52. 8.9.3 Alfact Innovation Alcoholic Hepatiti Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alfact Innovation Alcoholic Hepatiti Drug Product Portfolio
  54. 8.9.5 Alfact Innovation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alcoholic Hepatiti Drug Value Chain Analysis
  2. 9.1.1 Alcoholic Hepatiti Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alcoholic Hepatiti Drug Production Mode & Process
  6. 9.2 Alcoholic Hepatiti Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alcoholic Hepatiti Drug Distributors
  9. 9.2.3 Alcoholic Hepatiti Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst